文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Data Collection and Management of mHealth, Wearables, and Internet of Things in Digital Behavioral Health Interventions With the Awesome Data Acquisition Method (ADAM): Development of a Novel Informatics Architecture.

作者信息

Pulantara I Wayan, Wang Yuhan, Burke Lora E, Sereika Susan M, Bizhanova Zhadyra, Kariuki Jacob K, Cheng Jessica, Beatrice Britney, Loar India, Cedillo Maribel, Conroy Molly B, Parmanto Bambang

机构信息

School of Health and Rehabilitation Science, University of Pittsburgh, Pittsburgh, PA, United States.

School of Nursing, University of Pittsburgh, Pittsburgh, PA, United States.

出版信息

JMIR Mhealth Uhealth. 2024 Aug 7;12:e50043. doi: 10.2196/50043.


DOI:10.2196/50043
PMID:39113371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11322796/
Abstract

The integration of health and activity data from various wearable devices into research studies presents technical and operational challenges. The Awesome Data Acquisition Method (ADAM) is a versatile, web-based system that was designed for integrating data from various sources and managing a large-scale multiphase research study. As a data collecting system, ADAM allows real-time data collection from wearable devices through the device's application programmable interface and the mobile app's adaptive real-time questionnaires. As a clinical trial management system, ADAM integrates clinical trial management processes and efficiently supports recruitment, screening, randomization, data tracking, data reporting, and data analysis during the entire research study process. We used a behavioral weight-loss intervention study (SMARTER trial) as a test case to evaluate the ADAM system. SMARTER was a randomized controlled trial that screened 1741 participants and enrolled 502 adults. As a result, the ADAM system was efficiently and successfully deployed to organize and manage the SMARTER trial. Moreover, with its versatile integration capability, the ADAM system made the necessary switch to fully remote assessments and tracking that are performed seamlessly and promptly when the COVID-19 pandemic ceased in-person contact. The remote-native features afforded by the ADAM system minimized the effects of the COVID-19 lockdown on the SMARTER trial. The success of SMARTER proved the comprehensiveness and efficiency of the ADAM system. Moreover, ADAM was designed to be generalizable and scalable to fit other studies with minimal editing, redevelopment, and customization. The ADAM system can benefit various behavioral interventions and different populations.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/274241d027ad/mhealth-v12-e50043-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/92c2b48a9ac4/mhealth-v12-e50043-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/ca56e4c94d1a/mhealth-v12-e50043-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/9f4ca30634d3/mhealth-v12-e50043-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/7183df022316/mhealth-v12-e50043-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/844d5c03f131/mhealth-v12-e50043-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/dca101dbdb38/mhealth-v12-e50043-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/274241d027ad/mhealth-v12-e50043-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/92c2b48a9ac4/mhealth-v12-e50043-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/ca56e4c94d1a/mhealth-v12-e50043-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/9f4ca30634d3/mhealth-v12-e50043-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/7183df022316/mhealth-v12-e50043-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/844d5c03f131/mhealth-v12-e50043-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/dca101dbdb38/mhealth-v12-e50043-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/089e/11322796/274241d027ad/mhealth-v12-e50043-g007.jpg

相似文献

[1]
Data Collection and Management of mHealth, Wearables, and Internet of Things in Digital Behavioral Health Interventions With the Awesome Data Acquisition Method (ADAM): Development of a Novel Informatics Architecture.

JMIR Mhealth Uhealth. 2024-8-7

[2]
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.

Trials. 2021-10-11

[3]
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.

Trials. 2021-6-22

[4]
Internet of things-based smart wearable system to monitor sports person health.

Technol Health Care. 2021

[5]
Impact of Personal Health Records and Wearables on Health Outcomes and Patient Response: Three-Arm Randomized Controlled Trial.

JMIR Mhealth Uhealth. 2019-1-4

[6]
Perceptions of Wearable Health Tools Post the COVID-19 Emergency in Low-Income Latin Communities: Qualitative Study.

JMIR Mhealth Uhealth. 2024-5-8

[7]
RADAR-Base: Open Source Mobile Health Platform for Collecting, Monitoring, and Analyzing Data Using Sensors, Wearables, and Mobile Devices.

JMIR Mhealth Uhealth. 2019-8-1

[8]
Digital health innovations in urology: telemedicine, wearables, and mobile applications - a systematic review of literature.

Curr Opin Urol. 2024-3-1

[9]
Using Smartphones and Wearable Devices to Monitor Behavioral Changes During COVID-19.

J Med Internet Res. 2020-9-25

[10]
Wearable-Based Mobile Health App in Gastric Cancer Patients for Postoperative Physical Activity Monitoring: Focus Group Study.

JMIR Mhealth Uhealth. 2019-4-23

引用本文的文献

[1]
Adherence to self-monitoring and behavioral goals is associated with improved weight loss in an mHealth randomized-controlled trial.

Obesity (Silver Spring). 2025-3

本文引用的文献

[1]
The Effect of Tailored, Daily, Smartphone Feedback to Lifestyle Self-Monitoring on Weight Loss at 12 Months: the SMARTER Randomized Clinical Trial.

J Med Internet Res. 2022-7-5

[2]
Effect of tailored, daily feedback with lifestyle self-monitoring on weight loss: The SMARTER randomized clinical trial.

Obesity (Silver Spring). 2022-1

[3]
The daily Self-Weighing for Obesity Management in Primary Care Study: Rationale, design and methodology.

Contemp Clin Trials. 2021-8

[4]
Frequency of Self-Weighing and Weight Change: Cohort Study With 10,000 Smart Scale Users.

J Med Internet Res. 2021-6-28

[5]
Adherence to walking exercise prescription during pulmonary rehabilitation in COPD with a commercial activity monitor: a feasibility trial.

BMC Pulm Med. 2021-1-18

[6]
Patterns of Use and Key Predictors for the Use of Wearable Health Care Devices by US Adults: Insights from a National Survey.

J Med Internet Res. 2020-10-16

[7]
The SMARTER Trial: Design of a trial testing tailored mHealth feedback to impact self-monitoring of diet, physical activity, and weight.

Contemp Clin Trials. 2020-4

[8]
Weight variability during self-monitored weight loss predicts future weight loss outcome.

Int J Obes (Lond). 2020-6

[9]
Comparison of Physical Activity Measures Derived From the Fitbit Flex and the ActiGraph GT3X+ in an Employee Population With Chronic Knee Symptoms.

ACR Open Rheumatol. 2020-1

[10]
Evolution of Wearable Devices with Real-Time Disease Monitoring for Personalized Healthcare.

Nanomaterials (Basel). 2019-5-29

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索